Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
intoxication accidentelle par la warfarine sodique |
Causative agent (attribute) |
False |
Warfarin sodium |
Inferred relationship |
Some |
1 |
intoxication intentionnelle par la warfarine sodique |
Causative agent (attribute) |
False |
Warfarin sodium |
Inferred relationship |
Some |
1 |
intoxication par la warfarine sodique d'intention indéterminée |
Causative agent (attribute) |
False |
Warfarin sodium |
Inferred relationship |
Some |
|
intoxication par la warfarine sodique |
Causative agent (attribute) |
False |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Warfarin sodium |
Inferred relationship |
Some |
|
Warfarin sodium 3 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Warfarin sodium |
Inferred relationship |
Some |
|
Warfarin sodium 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Warfarin sodium |
Inferred relationship |
Some |
|
Product containing precisely warfarin sodium 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Warfarin sodium |
Inferred relationship |
Some |
|
Warfarin sodium 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Warfarin sodium |
Inferred relationship |
Some |
|
Warfarin sodium 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Warfarin sodium |
Inferred relationship |
Some |
|
Warfarin sodium 7.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Warfarin sodium |
Inferred relationship |
Some |
|
Warfarin sodium 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Warfarin sodium |
Inferred relationship |
Some |
|
Warfarin sodium 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Warfarin sodium |
Inferred relationship |
Some |
|
Warfarin sodium 6 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Warfarin sodium |
Inferred relationship |
Some |
|
Warfarin 2mg/mL powder for injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Warfarin sodium |
Inferred relationship |
Some |
|
intoxication par la warfarine sodique d'intention indéterminée |
Causative agent (attribute) |
False |
Warfarin sodium |
Inferred relationship |
Some |
1 |
surdose intentionnelle de warfarine sodique |
Causative agent (attribute) |
False |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 1 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 3 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 3 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Product containing precisely warfarin sodium 500 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Product containing precisely warfarin sodium 500 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 4 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 2 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 7.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 7.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 2.5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 6 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 6 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 4 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 2 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 2.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 6 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 7.5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 1 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 3 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Product containing precisely warfarin sodium 500 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 5 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Warfarin sodium |
Inferred relationship |
Some |
1 |
Warfarin sodium 5 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Warfarin sodium |
Inferred relationship |
Some |
1 |